• Cancel
    Date:2021-10
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=797

    Shanghai BiOligo Biotech Co., Ltd. (referred to as "BiOligo"), a leading supplier of in vitro diagnostics and nucleic acid drug raw materials, recently closed a RMB 300 million Series A financing. The funding was led by The Carlyle Group, a global leading

  • Cancel
    Date:2021-09
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=789

    On September 26th, Peak Sports, a leading sports brand in China, announced a strategic investment of nearly RMB 1.5 billion from China Resources Guodiao Xiamen Consumption Fund, with participation from several state-owned fund companies such as CCB Trust

  • Cancel
    Date:2021-09
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=800

    Xinyi Information Technology, a provider of Internet of Things (IoT) intelligent terminal system SoC chips, recently closed nearly RMB 500 million in its Series B financing. The funds will primarily be used to strengthen chip research and development, imp

  • Cancel
    Date:2021-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=801

    OrbusNeich Medical Group Limited ("OrbusNeich"), a global leader in vascular intervention devices, recently announced it successfully raised $200 million, led by Shenzhen Capital Group, with participation from CCB International, Star River Capital, Wanhui

  • Cancel
    Date:2021-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=803

    Innovative drug development company Lynk Pharma recently announced the successful closing of a $50 million in its Series B financing. The round was led by Lilly Asian Ventures, with participation from New Alliance Capital and HeDa Investment., as well as

  • Cancel
    Date:2021-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=804

    ZuoYi Technology, a leading domestic medical artificial intelligence system development company, recently announced the successful closing of a RMB 100 million Series B financing. The round was led by Qiming Venture Partners, with participation from well-

  • Cancel
    Date:2021-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=805

    New SORL successfully closes a RMB 500 million Series A financing. The round was led by HengXu Capital, with participation from SPIC, AutoCapital, Ruijian Capital, as well as local state-owned enterprises like Wenzhou Transportation Group and upstream sup

  • Cancel
    Date:2021-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=806

    Wenheyou successfully closed a significant Series B financing with investment from HongShan, IDG Capital, Warburg Pincus, Country Garden Venture Capital, GIC, and CEC Fund, amongst others. CEC Capital Group served as the exclusive financial advisor fo

  • Cancel
    Date:2021-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=808

    Berry Oncology recently announced the successful raising of nearly RMB 700 million in its Series B1 financing, led by China Merchants Capital, with support from existing shareholders Qiming Venture Partners and Legend Capital. Other investment institution